United Arab Emirates Claims China’s Sinopharm Vaccine Is 100% Effective At Preventing Moderate And Severe Covid-19
TOPLINE The experimental vaccine developed by China National Pharmaceutical Group, also known as Sinopharm, is 86% effective at preventing Covid-19 infection and 100% effective at preventing severe and moderate disease, health officials from the United Arab Emirates announced Wednesday, although with scarce detail provided about the trial.
The UAE health ministry cited an interim analysis of a late-stage clinical trial involving 31,000 volunteers as the source of its information, though neither they nor Sinopharm provided any data from the trial to validate the claims such as how many participants were infected or how many actually received the vaccine.
The ministry said “no serious safety concerns” were observed, though, again, no information on side effects was provided.
The ministry said the announcement is a “significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.”
The ministry added that it had officially registered the vaccine at the request of the manufacturer, which it says could eventually lead to the shot’s widespread authorization.
FDA admits long list of possible negative side-effects of Covid 19 vaccine! The working list presented has 22 separate entries of “possible adverse event outcomes”
First on the list is “Guillain-Barré syndrome,” described as “a rare disorder in which your body's immune system attacks your nerves.” The syndrome has “no known cure” & it mortality rate is “4% to 7%.” In contrast, John Hopkins Univ estimates that the current % of deaths reportedly due to COVID-19 cases in the US, is only 1.9%
“Acute disseminated encephalomyelitis,” a “rare inflammatory condition that affects the brain and spinal cord,” is 2nd on the FDA’s list. 3rd is “Transverse myelitis,” a neurological disorder which inflames the spinal cord, causing “pain, muscle weakness, paralysis, sensory problems, or bladder and bowel dysfunction.”
Another possible outcome of a potential vaccine is “Anaphylaxis,” the severe allergic reaction which can lead to anaphylactic shock
A “stroke,” & “convulsions/seizures” are further possible side-effects, along with “Acute myocardial infarction” or heart attacks, inflammation of the muscles around the heart, & even death
FDA will likely scrutinize allergic reactions to Pfizer’s Covid vaccine in UK before clearing use in U.S., Trump vaccine chief says
PUBLISHED WED, DEC 9 20205:29 PM ESTUPDATED WED, DEC 9 20206:10 PM EST Noah Higgins-Dunn @HIGGINSDUNN Allergic reactions reported by U.K. health-care workers vaccinated against Covid-19 will likely be discussed before the FDA authorizes a vaccine in the U.S., medical experts said on Wednesday. However, the allergic reactions shouldn’t be a surprise, and people with underlying health conditions aren’t commonly included in clinical trials, they said. The FDA is set to convene a meeting of its Vaccines and Related Biological Products Advisory Committee, or VRBPAC, on Thursday to review Pfizer’s Covid-19 vaccine.
Shareholders to register with Vote2U ► Individual Shareholders The registration will open from 10:00 a.m., Tuesday, 17 November 2020 up to 10:00 a.m., Monday, 14 December 2020. a. Access website at https://web.vote2u.app b. Click “Sign Up” to sign up as a user. c. Read and indicate your acceptance of the ‘Privacy Policy’ and ‘Terms & Conditions’. Then click “Next”. d. Fill-in your details [(i) ensure your email address is valid, & (ii) create your own password]. Then click “Continue”. e. Upload a clear copy of your MyKAD for Malaysian (front only) or Passport for non-Malaysian. f. Registration as user completed. g. Your registration will be verified and an email notification will be sent to you. Please check your email. Note: If you have already signed up / registered as a user with Vote2U previously, you are not required to register again.
Those who want to join AGM, please take note of the above. The registration is still open!
Why this moron barking here@NPRA1985.What is your basis saying cannot go higher??!!! You FA cannot read,TA also failed.Top Glove is in heavy collection.They only need 2 3 days to up to more than RM1.Just waiting the right day.Surely all healtcare stock will follow suit.Prlexus will be among the most benefits of price changing due to less share at open market not like your Kanger moron.I'm waiting the right moment to ALL IN!!!
Hong Kong’s Ming Pao daily said in its editorial that there were grounds to believe that the UAE must have been stringent with the review and registration of the Chinese vaccine, given the country’s record of being transparent in its anti-virus policymaking and mass testing.
“The UAE also maintains sound ties with the West so sourcing vaccines from the United States or elsewhere should not be a grave challenge. If the Chinese vaccine is not safe or effective, there is no reason for the UAE to endorse Beijing’s vaccine propaganda and risk its own image and the health of its own people.
“Thus the UAE’s approval and its top leader’s injection of the SinoPharm vaccine have come as a much-needed vote of confidence that will help convince more countries. Diversified supply of vaccines, with viable alternatives from China, is key to ensuring fair and equitable access by poor countries,” said the op-ed.
SinoPharm revealed that senior officials in Egypt and Bahrain also took part in trials held there.
Prlexus follows glove theme. What are the chances of Prlexus price going up despite good QR result when the rest of the glove counters are down as institutions have generally already withdrawn from glove counters and moved on to recovery theme counters? Just keeping it real...Anyone care to speculate?
Mask and glove are two different story. At the beginning of October 2020, PRLEXUS share price surge due to strong earnings and leave the glove sectors behind. Study the history properly.
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
uncertainty93
238 posts
Posted by uncertainty93 > 2020-12-09 16:53 | Report Abuse
yesterday only one day show and now the price almost back to the price before yesterday.